Synthetic Patient A
H4Y-PT-2048 ยท Northstar Heart Institute
Synthetic demo data
No PHI/PII
Frontend on Vercel
Production data in AWS
SP
H4Y-PT-2048
active consent
granted access

Synthetic Patient A

DOB 18 Apr 1957 | FemaleNorthstar Heart InstituteLatest hospitalization: Mercy General Hospital, 12-18 Feb 2026
Active diagnoses
Aortic stenosis
Chronic kidney disease stage 3
Heart failure with preserved EF
Allergies
Penicillin
Current meds
Apixaban 5 mg BIDTorsemide 20 mg QDAtorvastatin 40 mg QD

Clinician dashboard

Northstar Heart Institute active review queue

Northstar Heart Institute
200
Recently viewed patients
18
Unresolved contradictions
205
Imported documents
3
Recent AI queries
Recent hospitalization

Admitted with worsening exertional dyspnea, ankle edema, and elevated NT-proBNP.

Missing-data alert

Conflicting apixaban dose

Clinician profile

Dr. Anna Kowalska

Role
clinician
Northstar Heart Institute
clinicianexpires 31 Dec 2026
Mercy General Hospital
clinicianexpires 30 Oct 2026
MedLab Diagnostics
clinicianexpires 30 Oct 2026
ClearView Imaging Center
clinicianexpires 30 Oct 2026

Clinical summary

Evidence-backed current state

Active diagnoses

Aortic stenosis, Chronic kidney disease stage 3, Heart failure with preserved EF

Medication history

Furosemide stopped and torsemide 20 mg daily started on discharge medication list.

Hospitalizations

Admitted with worsening exertional dyspnea, ankle edema, and elevated NT-proBNP.

Outdated information

Cardiac CT annulus perimeter 76 mm from 2024; potentially stale for TAVR planning.

Contradictions

Conflicting records are not auto-resolved

Conflicting apixaban dose
unresolved

Patient may have self-entered an older or adjusted dose after discharge.

Penicillin allergy present in discharge record but absent in portal list
unresolved

Patient-uploaded list may be incomplete; allergy reaction severity is missing.

Procedure planning relies on outdated CT measurement
under review

CT predates current intervention review and may not represent current anatomy.

Blood pressure plan needs confirmation
under review

The medication plan is conditional on one week of home BP readings.

Warfarin dose differs between discharge and portal list
unresolved

Portal medication list may not have been reconciled after discharge.

Overdue chest CT follow-up
under review

Follow-up imaging may have occurred outside connected organizations or is missing.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
unresolved

Synthetic demo conflict for clinician review workflow.

Synthetic medication reconciliation needed
under review

Synthetic demo conflict for clinician review workflow.

Laboratory snapshot

Latest abnormal and procedure-relevant values

hemoglobin
high
11.64 g/dL
COPD synthetic follow-up
CRP
high
18.32 mg/L
Lung nodule under oncology surveillance synthetic follow-up
CRP
normal
7 mg/L
Type 2 diabetes synthetic follow-up
NT-proBNP
high
1180.08 pg/mL
Heart failure with preserved EF synthetic follow-up

Access model

Server-side restrictions applied before AI retrieval

Patient identity
Authorized organizations
User membership
Clinician role
Patient consent
Permitted event types
Date range
Source accessibility

Privacy and platform boundary

PHI/PII controls before production use

v0/Vercel
Synthetic frontend demo and UI prototyping only. No PHI/PII or durable medical storage.
AWS
Production backend, data, documents, KMS, S3, AI, audit logs, and authorization services.
Data
Synthetic demo records; production identifiers must be pseudonymized and encrypted.
Audit
Every AI and access decision must be logged with redacted fields.

Clinician login

Demo role switcher for patient access and AI retrieval scope

200 accessible patients
Role
clinician
Active organization
Northstar Heart Institute
Memberships
4

Urgent review queue

Open clinical signals that need rapid analysis, acknowledgement, or decision support

61 critical
107 open
0 read
Needs decision
107
Critical now
61
Read this session
0
Synthetic Patient A
critical
selected
H4Y-PT-2048 ยท Northstar Heart Institute
1 critical laboratory result
1 AI-derived review flag
stale imaging may affect decision-making
3 unresolved contradictions
6 actionable signalslatest 6 May 2026
Synthetic Patient C
critical
H4Y-PT-4177 ยท Northstar Heart Institute
oncology or malignancy surveillance signal
1 AI-derived review flag
stale imaging may affect decision-making
2 unresolved contradictions
4 actionable signalslatest 10 Apr 2026
Synthetic Patient 004
critical
H4Y-PT-5000 ยท Northstar Heart Institute
1 critical laboratory result
1 AI-derived review flag
1 unresolved contradiction
data freshness: review-needed
3 actionable signalslatest 1 May 2026
Synthetic Patient 123
critical
H4Y-PT-5119 ยท Mercy General Hospital
oncology or malignancy surveillance signal
1 AI-derived review flag
1 unresolved contradiction
data freshness: review-needed
2 actionable signalslatest 1 May 2026
Synthetic Patient 048
critical
H4Y-PT-5044 ยท Mercy General Hospital
oncology or malignancy surveillance signal
1 AI-derived review flag
data freshness: stale
1 actionable signallatest 6 May 2026
Synthetic Patient 038
critical
H4Y-PT-5034 ยท Mercy General Hospital
oncology or malignancy surveillance signal
1 AI-derived review flag
1 unresolved contradiction
2 actionable signalslatest 4 May 2026
Synthetic Patient 103
critical
H4Y-PT-5099 ยท Northstar Heart Institute
oncology or malignancy surveillance signal
1 AI-derived review flag
data freshness: stale
1 actionable signallatest 2 May 2026
Synthetic Patient 193
critical
H4Y-PT-5189 ยท Northstar Heart Institute
oncology or malignancy surveillance signal
1 AI-derived review flag
data freshness: review-needed
1 actionable signallatest 6 May 2026

Patient search

Select a synthetic patient to review data and analytics

200 visible
Synthetic Patient A
selected
granted
H4Y-PT-2048 ยท Northstar Heart Institute ยท DOB 18 Apr 1957
SP
H4Y-PT-2048
active consent
granted access

Synthetic Patient A

DOB 18 Apr 1957 | FemaleNorthstar Heart InstituteLatest hospitalization: Mercy General Hospital, 12-18 Feb 2026
Active diagnoses
Aortic stenosis
Chronic kidney disease stage 3
Heart failure with preserved EF
Allergies
Penicillin
Current meds
Apixaban 5 mg BIDTorsemide 20 mg QDAtorvastatin 40 mg QD

Clinician dashboard

Northstar Heart Institute active review queue

Northstar Heart Institute
200
Recently viewed patients
3
Unresolved contradictions
4
Imported documents
1
Recent AI queries
Recent hospitalization

Admitted with worsening exertional dyspnea, ankle edema, and elevated NT-proBNP.

Missing-data alert

Conflicting apixaban dose

Clinician profile

Dr. Anna Kowalska

Role
clinician
Northstar Heart Institute
clinicianexpires 31 Dec 2026
Mercy General Hospital
clinicianexpires 30 Oct 2026
MedLab Diagnostics
clinicianexpires 30 Oct 2026
ClearView Imaging Center
clinicianexpires 30 Oct 2026

Clinical summary

Evidence-backed current state

Active diagnoses

Aortic stenosis, Chronic kidney disease stage 3, Heart failure with preserved EF

Medication history

Furosemide stopped and torsemide 20 mg daily started on discharge medication list.

Hospitalizations

Admitted with worsening exertional dyspnea, ankle edema, and elevated NT-proBNP.

Outdated information

Cardiac CT annulus perimeter 76 mm from 2024; potentially stale for TAVR planning.

Contradictions

Conflicting records are not auto-resolved

Conflicting apixaban dose
unresolved

Patient may have self-entered an older or adjusted dose after discharge.

Penicillin allergy present in discharge record but absent in portal list
unresolved

Patient-uploaded list may be incomplete; allergy reaction severity is missing.

Procedure planning relies on outdated CT measurement
under review

CT predates current intervention review and may not represent current anatomy.

Laboratory snapshot

Latest abnormal and procedure-relevant values

eGFR
low
39 mL/min/1.73m2
Post-discharge nephrology follow-up
hemoglobin
low
11.2 g/dL
Heart failure hospitalization
potassium
normal
4.8 mmol/L
Heart failure hospitalization
NT-proBNP
critical
3150 pg/mL
Heart failure hospitalization

Access model

Server-side restrictions applied before AI retrieval

Patient identity
Authorized organizations
User membership
Clinician role
Patient consent
Permitted event types
Date range
Source accessibility

Privacy and platform boundary

PHI/PII controls before production use

v0/Vercel
Synthetic frontend demo and UI prototyping only. No PHI/PII or durable medical storage.
AWS
Production backend, data, documents, KMS, S3, AI, audit logs, and authorization services.
Data
Synthetic demo records; production identifiers must be pseudonymized and encrypted.
Audit
Every AI and access decision must be logged with redacted fields.